Brain cells playing Doom & Breakthrough injections for cancer - News (Jun 1, 2026)
Lab-grown brain cells learn Doom, a promising cancer injection, AI memory chips hit $1T, US-Iran escalation near Hormuz, and Ukraine’s drone war—June 1, 2026.
Our Sponsors
Today's Top News Topics
-
Brain cells playing Doom
— Researchers in Melbourne trained lab-grown human neurons on a chip to play Doom, highlighting adaptive learning and potential energy-efficient computing beyond today’s AI. -
Breakthrough injections for cancer
— A triple-action cancer injection, amivantamab, showed unusually strong responses in hard-to-treat head and neck cancer, while Johnson & Johnson reported improved outcomes for high-risk localized prostate cancer around surgery. -
AI chip boom and bottlenecks
— Micron and SK Hynix topping $1 trillion market caps spotlights high-bandwidth memory as a key AI data-center bottleneck, while Nvidia says “AI factories” and AI agents are reshaping investment and jobs. -
US-Iran strikes and Hormuz
— The US said it struck Iranian radar and drone command sites after a drone incident, Iran signaled retaliation, and the Strait of Hormuz remains effectively blocked—raising global oil and LNG supply concerns. -
Ukraine strikes, children allegations
— Ukraine hit Russian oil facilities with long-range drones as Russia warned of broader strikes; Zelenskyy also alleged child abductions and forced training—adding pressure for investigations and sanctions. -
AI helping artists create
— Singer-songwriter Samuel Smith used AI music tools as an assistive creative bridge after Parkinson’s limited his guitar playing, underscoring AI’s growing role in preserving artistic intent.
Sources & Top News References
- → Trial Finds Amivantamab Injection Can Eliminate Tumours in Some Advanced Head and Neck Cancer Patients
- → Micron and SK Hynix Hit $1 Trillion as AI High-Bandwidth Memory Demand Surges
- → US Hits Iranian Radar Sites as Iran Targets US Base in Kuwait
- → Lab-Grown Human Neurons on a Chip Trained to Play Doom
- → Ukraine Steps Up Drone Strikes on Russian Oil Sites as Kyiv Braces for More Attacks
- → Nvidia’s Jensen Huang Says AI Is Now Driving Profits and GDP, Unveils New AI-PC Chip in Taipei
- → Parkinson’s-Stricken Musician Uses AI to Finish New Album
- → Erleada plus hormone therapy around surgery shows major gains in high-risk prostate cancer trial
- → Zelenskyy says Russia abducts Ukrainian children and trains them to fight
Full Episode Transcript: Brain cells playing Doom & Breakthrough injections for cancer
What if I told you a dish of lab-grown human brain cells just learned to play Doom—and got better with practice? Welcome to The Automated Daily, top news edition. The podcast created by generative AI. I’m TrendTeller, and today is June 1st, 2026. We’ll move from a surprising leap in biological computing, to major cancer-trial results, to the AI chip boom reshaping markets—then close with fast-moving developments in the Middle East and Ukraine.
Brain cells playing Doom
Let’s start with the story that sounds like science fiction. Researchers at Melbourne-based Cortical Labs say they’ve trained lab-grown human neurons—living on a silicon chip—to play the classic shooter game Doom. The neurons didn’t start out skilled. Early on, they behaved like a clueless beginner: bumping into walls, firing randomly, and getting nowhere fast. But with continued training, the cultures began to respond more purposefully, increasingly targeting enemies and adapting in real time. This isn’t about turning brain cells into gamers. The bigger idea is that biology learns with very low energy use compared with today’s power-hungry computing. The team says platforms like this could eventually help with drug testing and disease modeling, even if it’s still early and the neuron cultures don’t last long.
Breakthrough injections for cancer
Now to medicine, where two cancer updates are drawing attention ahead of the American Society of Clinical Oncology meeting. First: doctors reported what they called “unprecedented” results from an international trial of amivantamab, a triple-action injection for people with recurrent or metastatic head and neck cancer that had stopped responding to standard chemotherapy and immunotherapy. In a study spanning 11 countries and 102 patients, tumors shrank or disappeared in 43 people. Fifteen patients saw their tumors vanish entirely, and some changes showed up within weeks. What makes this especially notable is the setting: once head and neck cancers reach this stage—often HPV-negative—the options can be limited and outcomes are typically poor. The treatment is delivered as an under-the-skin jab every three weeks, potentially simpler than regular intravenous infusions. Side effects were mostly mild to moderate, and fewer than one in ten people stopped treatment. Median overall survival after starting therapy was reported at 12.5 months—an important signal in a group where the bar is painfully low.
AI chip boom and bottlenecks
The second cancer story comes from Johnson & Johnson in high-risk prostate cancer—earlier-stage disease, but still one that frequently comes back after today’s standard treatment. In a late-stage trial, adding the drug Erleada to standard testosterone-suppressing hormone therapy around the time of prostate-removal surgery improved outcomes in men with high-risk localized or locally advanced cancer. Patients on the combination were far more likely to have minimal to no detectable cancer at surgery, and the company reported meaningful reductions in the risk of progression or death. If these results hold up and regulators agree, it could change the treatment playbook for a large group of patients—especially since a significant share of prostate cancer diagnoses in the US fall into the high-risk category.
US-Iran strikes and Hormuz
Shifting to technology and markets: memory chips—long treated as a commodity corner of the semiconductor world—are now being priced like strategic infrastructure for AI. Micron and South Korea’s SK Hynix have both climbed to market values above one trillion dollars. The driver is high-bandwidth memory, or HBM, which has become a choke point for AI data centers. In plain terms: AI systems can be limited not only by how fast they compute, but by how quickly they can access the right data. When that kind of memory is scarce, the suppliers gain leverage—through demand, through pricing power, and through longer-term orders that look less “boom and bust” than past chip cycles. The broader takeaway is that investors are increasingly treating memory as essential to AI growth, not just a cyclical bet that rises and falls with gadget demand.
Ukraine strikes, children allegations
And speaking of AI hardware, Nvidia’s CEO Jensen Huang used GTC Taipei to argue that AI has moved from experiments to profit engines—and even a contributor to GDP growth. Huang’s core message was that companies are building “AI factories” because the output of AI—what he framed as a flood of usable work products—can be monetized. He also pushed back on the idea that AI automatically means fewer jobs, saying AI-assisted coding can increase productivity and, in some cases, lead to hiring more engineers. He predicted that “AI agents” will become a kind of digital labor force, eventually numbering in the billions. Whether you buy the timeline or not, the direction is clear: companies are betting that software that can plan, remember, and act will be a major new layer of the economy.
AI helping artists create
Now to the Middle East, where tensions around the Strait of Hormuz are escalating again—with implications that extend well beyond the region. The US says it carried out weekend “self-defence” strikes on Iranian radar and drone command-and-control sites near Iran’s southern coast and on Qeshm Island, following what Washington described as aggressive Iranian actions, including the downing of a US drone over international waters. Iran’s Revolutionary Guard said it responded by targeting an air base in Kuwait used by US forces. Kuwait reported hostile missiles and drones, and air-raid sirens reportedly sounded nationwide. US Central Command said two Iranian ballistic missiles aimed at US forces in Kuwait were intercepted, and that no American personnel were hurt. This is the third major escalation in a week, and the Strait of Hormuz remains effectively blocked—a critical problem for global oil and LNG shipments. Ceasefire-extension talks appear to be stalling, with reports that proposed terms and demands are shifting. The key risk here is miscalculation: even limited tit-for-tat actions can rattle energy markets when the shipping lane is already constrained.
Turning to Ukraine: overnight drone strikes set fires at Russian oil facilities, according to Russian officials, including reported damage in Taganrog in the Rostov region and a separate fire in Armavir in the Krasnodar region. President Volodymyr Zelenskyy highlighted that Armavir is roughly 500 kilometers from Ukraine’s border—an underscore of Ukraine’s growing long-range reach. The strategy is straightforward: oil infrastructure helps fund Russia’s war effort, and disrupting it can raise costs and create logistical headaches. Russia, meanwhile, continues long-range attacks on Ukrainian cities and infrastructure, and Kyiv is bracing for what Moscow has called broader “systemic strikes.” Zelenskyy is again urging the US for more Patriot air defenses. Tensions also rose after a Russian drone strike injured two people in Romania, a NATO member—fueling concern about spillover. And in another reminder of the risks, Russia’s Rosatom said a Ukrainian drone hit the Russian-controlled Zaporizhzhia nuclear power plant, causing minor damage but no reported harm to critical equipment. The IAEA has warned repeatedly: even small incidents at a nuclear site carry outsized danger.
One more Ukraine-related development is drawing sharp scrutiny. Zelenskyy told CBS News that Ukraine has evidence Russia is abducting Ukrainian children and training them to fight against Ukrainians—an allegation that, if proven, would intensify war-crimes concerns. The claim goes beyond earlier reporting about children being sent to camps for reeducation or “Russification.” Zelenskyy also said children are being treated as bargaining chips, offered in exchanges for captured soldiers—something he argues is plainly illegal under international humanitarian law. Ukraine says it has documented at least 20,000 abducted children. Russia has framed its actions as humanitarian care for war orphans, but the International Criminal Court issued an arrest warrant for Vladimir Putin in 2023 over alleged unlawful deportation of children. The next question is whether international bodies and governments can verify new evidence quickly—and what pressure follows.
Finally, a quieter story about AI’s role in everyday life—this time in music. London-based singer-songwriter Samuel Smith, diagnosed with Parkinson’s disease in 2020, has been using AI tools as his condition has taken away much of his ability to play guitar. He recently released a second album, and used AI music-generation platforms to help shape at least one track—creating demo arrangements to communicate structure and feel to the musicians who recorded the final version. It’s a useful reminder that AI isn’t only about speed or automation. In some cases, it’s assistive technology—helping people keep creating when the body won’t cooperate, and preserving personal artistic intent.
That’s the top news for today. If you’re keeping score, the big themes are capability and constraint: new medical options where choices were running out, new computing power—and new bottlenecks—driving markets, and geopolitical flashpoints where a single decision can tighten global supply lines. Thanks for listening to The Automated Daily, top news edition. I’m TrendTeller—see you next time.
That wraps our June 1st, 2026 edition. If you want to keep up with how these stories evolve—especially the cancer trial data, the AI chip supply crunch, and the risk around Hormuz—follow the show for your next update. Until tomorrow, I’m TrendTeller.
More from Top News
- May 30, 2026 Gene test to skip chemo & Hepatitis B drug functional cure
- May 29, 2026 Webb spots outsized early black hole & GSK hepatitis B drug boosts cures
- May 27, 2026 Vatican targets AI power & Single-shot cholesterol gene editing
- May 26, 2026 Single-shot gene editing for LDL & Vatican calls for AI laws
- May 25, 2026 Pope’s push to regulate AI & Diplomacy to end US-Iran war